AXSM
$61.51
Axsome Thera
($2.41)
(3.77%)
AXSM
Earnings Whisper ®
N/A
1st Quarter March 2023
Consensus:  ($1.14)
Revenue:  $27.65 Mil
Monday
May 29
7:00 AM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when AXSM reports earnings?
Beat
Meet
Miss

Where is AXSM's stock price going from here?
Up
Flat
Down
Stock chart of AXSM
Analysts
Summary of analysts' recommendations for AXSM
Score
Grade
Pivots
Resistance
$67.22
$65.77
$63.64

$62.19

Support
$60.06
$58.61
$56.48
Tweet
Growth
Description
Axsome Therapeutics, Inc. is a biopharmaceutical company. The company is focused on developing novel therapies for the management of pain and other central nervous system disorders. Its product candidate portfolio consists of AXS-02 and AXS-05 which are in clinical trial stage. Axsome Therapeutics, Inc. is based in New York.
›